We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
IntelliPharmaCeutics International Inc (QB) | USOTC:IPCIF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.06 | 0.0379 | 0.12 | 0.075 | 0.06 | 0.075 | 7,501 | 21:00:06 |
|
|
Intellipharmaceutics
International Inc.
(Registrant)
/s/
Domenic Della Penna
|
Date: July 26, 2017
|
|
Domenic Della Penna
Chief Financial Officer
|
Exhibit
|
Description
|
99.1
|
News Release dated July 26, 2017 - Intellipharmaceutics Provides
Update on FDA Advisory Committees Meeting for Rexista™
(oxycodone hydrochloride extended release), an Abuse-Deterrent
Opioid Analgesic for the Treatment of Moderate to Severe
Pain
|
|
|
|
|
|
|
|
|
1 Year IntelliPharmaCeutics (QB) Chart |
1 Month IntelliPharmaCeutics (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions